OACC
Oaktree Acquisition Corp. III Life Sciences
$10.69
+0.00 (+0.00%)
At close · Jul 8
Market Cap
$262.79M
Shares
24,582,768
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-10-29 | Martinez George Arthur |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2025-10-17 | BERRY DAVID A |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-06-03 | Sweeney Thomas |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Pendo Mathew |
Chief Operating Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Conigliaro Courtney |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Frank John |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | MEISTER PAUL M |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Shih Alvin |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Pardesi Zaid |
Chief Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-10-23 | Kumar Aman |
Director |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–10 of 10 transactions